CN110623269A - Composition for meeting nutritional requirements of diabetic patients and preparation method thereof - Google Patents
Composition for meeting nutritional requirements of diabetic patients and preparation method thereof Download PDFInfo
- Publication number
- CN110623269A CN110623269A CN201910969761.0A CN201910969761A CN110623269A CN 110623269 A CN110623269 A CN 110623269A CN 201910969761 A CN201910969761 A CN 201910969761A CN 110623269 A CN110623269 A CN 110623269A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- polysaccharide
- compound
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 17
- 206010012601 diabetes mellitus Diseases 0.000 title claims description 21
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 150000004676 glycans Chemical class 0.000 claims abstract description 68
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 68
- 239000005017 polysaccharide Substances 0.000 claims abstract description 68
- 150000001875 compounds Chemical class 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 29
- 235000013305 food Nutrition 0.000 claims abstract description 23
- 229940088594 vitamin Drugs 0.000 claims abstract description 22
- 229930003231 vitamin Natural products 0.000 claims abstract description 22
- 235000013343 vitamin Nutrition 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 21
- 239000011707 mineral Substances 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 17
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 17
- 241000206609 Porphyra Species 0.000 claims abstract description 17
- -1 compound vitamin Chemical class 0.000 claims abstract description 17
- 235000013312 flour Nutrition 0.000 claims abstract description 17
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 17
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 15
- 229920002101 Chitin Polymers 0.000 claims abstract description 14
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 14
- 244000269722 Thea sinensis Species 0.000 claims abstract description 14
- 150000001746 carotenes Chemical class 0.000 claims abstract description 14
- 235000005473 carotenes Nutrition 0.000 claims abstract description 14
- 235000009569 green tea Nutrition 0.000 claims abstract description 14
- 239000001814 pectin Substances 0.000 claims abstract description 14
- 229920001277 pectin Polymers 0.000 claims abstract description 14
- 235000010987 pectin Nutrition 0.000 claims abstract description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 14
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 14
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920002752 Konjac Polymers 0.000 claims abstract description 13
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 20
- 108010024636 Glutathione Proteins 0.000 claims description 13
- 229960003180 glutathione Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 238000004806 packaging method and process Methods 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 8
- 238000013329 compounding Methods 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- 229930003537 Vitamin B3 Natural products 0.000 claims description 5
- 229930003571 Vitamin B5 Natural products 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 235000021329 brown rice Nutrition 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 5
- 229960002079 calcium pantothenate Drugs 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000011630 iodine Substances 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 235000006180 nutrition needs Nutrition 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229960003495 thiamine Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 235000019160 vitamin B3 Nutrition 0.000 claims description 5
- 239000011708 vitamin B3 Substances 0.000 claims description 5
- 239000011675 vitamin B5 Substances 0.000 claims description 5
- 235000009492 vitamin B5 Nutrition 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- 235000015099 wheat brans Nutrition 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 235000010755 mineral Nutrition 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 244000247812 Amorphophallus rivieri Species 0.000 abstract description 5
- 235000001206 Amorphophallus rivieri Nutrition 0.000 abstract description 5
- 239000000252 konjac Substances 0.000 abstract description 5
- 235000010485 konjac Nutrition 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 241000699670 Mus sp. Species 0.000 description 15
- 235000013325 dietary fiber Nutrition 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 206010061481 Renal injury Diseases 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 235000014590 basal diet Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000037806 kidney injury Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000007410 oral glucose tolerance test Methods 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a composition for meeting the nutritional requirements of diabetics and a preparation method thereof, wherein the composition comprises the following components in percentage by mass: 15-20 parts of low-ester pectin, 15-20 parts of chitin, 15-25 parts of konjac flour, 4-10 parts of compound vitamin, 2-4 parts of carotene, 35-45 parts of compound staple food powder, 2-6 parts of compound mineral substance and 1-3 parts of green tea polyphenol; the soybean polysaccharide, the fructo-oligosaccharide, the agaric polysaccharide, the porphyra polysaccharide, the algal polysaccharide and the konjac powder have the effect of reducing blood sugar, have a good effect of reducing the concentration of the blood sugar, and the multivitamins and the compound staple food powder can provide nutrients which are caused by or possibly lost due to the fact that the diabetics cannot normally eat various foods, and can repair the damaged liver and kidney caused by imbalance of the blood sugar.
Description
Technical Field
The invention relates to the field of formula foods with special medical application, in particular to a composition meeting the nutritional requirements of diabetics and a preparation method thereof.
Background
Diabetes patients cause a series of metabolic disorders such as sugar, protein, fat, water and electrolyte due to genetic factors, endocrine dysfunction and the like. The control of blood sugar is vital to diabetes, at present, the diabetes mostly reduces the blood sugar by orally taking hypoglycemic drugs or injecting insulin, but the two modes of controlling the blood sugar are controlled by adopting drugs or hormones, the chronic kidney injury can be caused to the diabetes due to overlarge dosage, if the blood sugar can be reduced by diet in daily life, the dosage of the hypoglycemic drugs of the diabetes can be reduced, and the kidney injury of the diabetes can be delayed or relieved, therefore, the invention provides the composition meeting the nutritional requirements of the diabetes and the preparation method thereof, so as to solve the defects in the prior art.
Disclosure of Invention
In order to solve the problems, the invention provides a composition meeting the nutritional requirements of diabetics and a preparation method thereof. The soybean polysaccharide, the fructo-oligosaccharide, the agaric polysaccharide, the porphyra polysaccharide, the seaweed polysaccharide and the konjac flour are dietary fiber raw materials, all have the effect of reducing blood sugar, and the compound vitamin and the compound staple food powder can provide nutrients which are caused or possibly lost by being incapable of normally eating various foods for diabetics.
The invention provides a composition for meeting the nutritional requirements of diabetics, which comprises the following components in percentage by mass: 15-20 parts of low-ester pectin, 15-20 parts of chitin, 8-10 parts of soybean polysaccharide, 6-8 parts of fructo-oligosaccharide, 6-8 parts of agaric polysaccharide, 6-8 parts of porphyra polysaccharide, 6-8 parts of algal polysaccharide, 15-25 parts of konjaku flour, 3-7 parts of glutathione, 4-10 parts of compound vitamin, 2-4 parts of carotene, 35-45 parts of compound staple food powder, 2-6 parts of compound mineral substance and 1-3 parts of green tea polyphenol.
The further improvement lies in that: comprises the following components in percentage by mass: 18 parts of low-ester pectin, 17 parts of chitin, 9 parts of soybean polysaccharide, 7 parts of fructo-oligosaccharide, 7 parts of agaric polysaccharide, 7 parts of porphyra polysaccharide, 7 parts of algal polysaccharide, 20 parts of konjaku flour, 5 parts of glutathione, 7 parts of compound vitamin, 3 parts of carotene, 40 parts of compound staple food powder, 4 parts of compound mineral substance and 2 parts of green tea polyphenol.
The further improvement lies in that: the compound vitamin is prepared by compounding vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K and folic acid according to the mass ratio of 1:1.5:1:0.5:3:2:3:0.5:0.5:0.8: 1.
The further improvement lies in that: the composite staple food powder is prepared by compounding fine grinding powder of oat, oatmeal, corn flour, brown rice and wheat bran according to the mass ratio of 1:1:0.5:0.5: 0.5.
The further improvement lies in that: the compound mineral is formed by compounding calcium, magnesium, potassium, sodium, phosphorus, chlorine, selenium, iron, zinc and iodine according to the mass ratio of 1:1:1:1:1:1:0.2:0.1: 0.05.
A method of preparing a composition for satisfying the nutritional needs of a diabetic patient, comprising the steps of:
the method comprises the following steps: mixing and stirring low-ester pectin, chitin, soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide, glutathione, compound vitamin, carotene and compound mineral substances, and then uniformly mixing for 6-8 minutes by a mixer to prepare a mixture A;
step two: mixing the mixture A with rhizoma Amorphophalli powder, rapidly parching at 100 deg.C for 5-7 min, naturally cooling, and mixing with green tea polyphenols to obtain composition;
step three: sterilizing the composition, packaging, inspecting quality, and packaging.
The invention has the beneficial effects that: soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide and konjac flour are dietary fiber raw materials, and all have the effect of reducing blood sugar, the dietary fibers can effectively control fasting blood sugar, postprandial blood sugar and glycohemoglobin and lipid metabolic disorders, the compound mineral substances can provide elements required by a human body, and have a good effect of reducing the blood sugar concentration, the compound vitamins and the compound staple food powder can provide nutrients which are caused or possibly lost by incapability of normally eating various foods for diabetics, can comprehensively improve the autoimmunity of the diabetics, repair damaged livers and kidneys caused by unbalanced blood sugar, and maintain the balance of hormone levels in the bodies.
Detailed Description
In order to further understand the present invention, the following detailed description will be made with reference to the following examples, which are only used for explaining the present invention and are not to be construed as limiting the scope of the present invention.
Example one
The composition for meeting the nutritional requirements of the diabetics comprises the following components in percentage by mass: 15 parts of low-ester pectin, 15 parts of chitin, 8 parts of soybean polysaccharide, 6 parts of fructo-oligosaccharide, 6 parts of agaric polysaccharide, 6 parts of porphyra polysaccharide, 6 parts of algal polysaccharide, 15 parts of konjaku flour, 3 parts of glutathione, 4 parts of compound vitamin, 2 parts of carotene, 35 parts of compound staple food powder, 2 parts of compound mineral substances and 1 part of green tea polyphenol.
The compound vitamin comprises vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K and folic acid.
The composite staple food powder comprises fine ground powder of oat, oatmeal, corn flour, brown rice and wheat bran.
The compound mineral comprises calcium, magnesium, potassium, sodium, phosphorus, chlorine, selenium, iron, zinc and iodine.
A method of preparing a composition for satisfying the nutritional needs of a diabetic patient, comprising the steps of:
the method comprises the following steps: mixing low-ester pectin, chitin, soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide, glutathione, vitamin complex, carotene and compound mineral substances, stirring, and uniformly mixing for 7 minutes by a mixer to prepare a mixture A.
Step two: mixing the mixture A with rhizoma Amorphophalli powder, rapidly parching at 100 deg.C for 6 min, naturally cooling, and mixing with green tea polyphenols to obtain the composition.
Step three: sterilizing the composition, packaging, inspecting quality, and packaging.
Example two
The composition for meeting the nutritional requirements of the diabetics comprises the following components in percentage by mass: 18 parts of low-ester pectin, 17 parts of chitin, 9 parts of soybean polysaccharide, 7 parts of fructo-oligosaccharide, 7 parts of agaric polysaccharide, 7 parts of porphyra polysaccharide, 7 parts of algal polysaccharide, 20 parts of konjaku flour, 5 parts of glutathione, 7 parts of compound vitamin, 3 parts of carotene, 40 parts of compound staple food powder, 4 parts of compound mineral substance and 2 parts of green tea polyphenol.
The compound vitamin comprises vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K and folic acid.
The composite staple food powder comprises fine ground powder of oat, oatmeal, corn flour, brown rice and wheat bran.
The compound mineral comprises calcium, magnesium, potassium, sodium, phosphorus, chlorine, selenium, iron, zinc and iodine.
A method of preparing a composition for satisfying the nutritional needs of a diabetic patient, comprising the steps of:
the method comprises the following steps: mixing low-ester pectin, chitin, soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide, glutathione, vitamin complex, carotene and compound mineral substances, stirring, and uniformly mixing for 7 minutes by a mixer to prepare a mixture A.
Step two: mixing the mixture A with rhizoma Amorphophalli powder, rapidly parching at 100 deg.C for 6 min, naturally cooling, and mixing with green tea polyphenols to obtain the composition.
Step three: sterilizing the composition, packaging, inspecting quality, and packaging.
EXAMPLE III
The composition for meeting the nutritional requirements of the diabetics comprises the following components in percentage by mass: 20 parts of low-ester pectin, 20 parts of chitin, 10 parts of soybean polysaccharide, 8 parts of fructo-oligosaccharide, 8 parts of agaric polysaccharide, 8 parts of porphyra polysaccharide, 8 parts of algal polysaccharide, 25 parts of konjaku flour, 7 parts of glutathione, 10 parts of compound vitamin, 4 parts of carotene, 45 parts of compound staple food powder, 6 parts of compound mineral substance and 3 parts of green tea polyphenol.
The compound vitamin comprises vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K and folic acid.
The composite staple food powder comprises fine ground powder of oat, oatmeal, corn flour, brown rice and wheat bran.
The compound mineral comprises calcium, magnesium, potassium, sodium, phosphorus, chlorine, selenium, iron, zinc, and iodine.
A method of preparing a composition for satisfying the nutritional needs of a diabetic patient, comprising the steps of:
the method comprises the following steps: mixing low-ester pectin, chitin, soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide, glutathione, vitamin complex, carotene and compound mineral substances, stirring, and uniformly mixing for 7 minutes by a mixer to prepare a mixture A.
Step two: mixing the mixture A with rhizoma Amorphophalli powder, rapidly parching at 100 deg.C for 6 min, naturally cooling, and mixing with green tea polyphenols to obtain the composition.
Step three: sterilizing the composition, packaging, inspecting quality, and packaging.
According to the first embodiment, the second embodiment and the third embodiment, the invention can be obtained by the following components in percentage by mass: 15-20 parts of low-ester pectin, 15-20 parts of chitin, 8-10 parts of soybean polysaccharide, 6-8 parts of fructo-oligosaccharide, 6-8 parts of agaric polysaccharide, 6-8 parts of porphyra polysaccharide, 6-8 parts of algal polysaccharide, 15-25 parts of konjaku flour, 3-7 parts of glutathione, 4-10 parts of compound vitamin, 2-4 parts of carotene, 35-45 parts of compound staple food powder, 2-6 parts of compound mineral substance and 1-3 parts of green tea polyphenol.
Effect experiment 1
300 male mice with the same growth cycle and a weight of 20-25 g were selected, then fed with basal feed for one week, and then the 300 male mice were divided into 3 groups, specifically, a blank group, a model group and a treatment group, each group including 100 male mice.
Feeding a blank group of male mice with a basal feed;
male mice in the model group and the treatment group are fed with high-calorie and high-sugar feed, and then are injected with Streptozotocin (STZ) (dissolved in 0.1 millimole/liter citric acid buffer solution, pH is 4.4) in a disposable intraperitoneal injection mode according to the dose of 20 mg/kg body weight; after 96 hours, the male white mice are fasted for 12 hours, and then are fed with 20 percent D-glucose solution by 2.5 g/kg body weight again to carry out an oral glucose tolerance test, and the success of molding is determined when the blood sugar is respectively more than 7.5 millimole/liter and 11.5 millimole/liter in 0 and 120 minutes.
The blank group of male mice was fed normally basal diet.
The male mice of the model group were normally fed with the basal diet.
Feeding male mice in a treatment group with the composition which meets the nutritional requirements of the diabetic patients and is prepared in any one of the first embodiment, the second embodiment or the third embodiment of the invention for three times at a time, wherein the feeding is 30 g;
after 30 days, oral glucose tolerance tests were performed on the male mice in the blank group, the model group and the treatment group, and the test results are shown in table 1:
TABLE 1
0 minute | 30 minutes | 60 minutes | 90 minutes | 120 minutes | |
Blank group | 5.32±1.18 | 6.38±2.18 | 14.1±2.58 | 13.5±3.01 | 12.6±1.58 |
Model set | 19.1±2.49 | 22.4±1.98 | 24.8±2.69 | 22.1±2.12 | 20.47±1.69 |
Treatment group | 17.0±1.05 | 17.9±1.95 | 19.5±2.05 | 18.0±1.01 | 13.21±0.56 |
As can be seen from the results in Table 1, the composition satisfying the nutritional requirements of the diabetic patients according to the present invention has an obvious effect of lowering blood sugar when fed to the treatment group.
Effect experiment two
After the effect experiment is finished, randomly selecting 5 cases of male mice in the model group and the treatment group for dissection, and observing the damage degrees of the liver and the kidney of the male mice in the model group and the treatment group, wherein the liver and the kidney of the male mice in the model group are damaged to a certain degree, the liver and the kidney of the male mice in the treatment group are repaired and healed, and the damage degree is lower than that of the male mice in the model group.
Soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide and konjac flour are raw materials of dietary fibers, and all have the effect of reducing blood sugar, the dietary fibers can effectively control fasting blood sugar, postprandial blood sugar, glycosylated hemoglobin and lipid metabolic disorder, the composite mineral can provide elements required by a human body, wherein cobalt element is one of trace elements necessary for islet cells, and has a good effect of reducing blood sugar concentration, the composite vitamin and the composite staple food powder can provide nutrients which are caused or possibly lost by abnormal eating of various foods for a diabetic patient, can comprehensively improve the autoimmunity of the patient, repair damaged liver and kidney caused by unbalanced blood sugar, and maintain the balance of hormone levels in the body.
Claims (6)
1. The composition for meeting the nutritional requirements of diabetics is characterized by comprising the following components in percentage by mass: 15-20 parts of low-ester pectin, 15-20 parts of chitin, 8-10 parts of soybean polysaccharide, 6-8 parts of fructo-oligosaccharide, 6-8 parts of agaric polysaccharide, 6-8 parts of porphyra polysaccharide, 6-8 parts of algal polysaccharide, 15-25 parts of konjaku flour, 3-7 parts of glutathione, 4-10 parts of compound vitamin, 2-4 parts of carotene, 35-45 parts of compound staple food powder, 2-6 parts of compound mineral substance and 1-3 parts of green tea polyphenol.
2. The composition according to claim 1, wherein the nutritional requirements of a diabetic patient are as follows: comprises the following components in percentage by mass: 18 parts of low-ester pectin, 17 parts of chitin, 9 parts of soybean polysaccharide, 7 parts of fructo-oligosaccharide, 7 parts of agaric polysaccharide, 7 parts of porphyra polysaccharide, 7 parts of algal polysaccharide, 20 parts of konjaku flour, 5 parts of glutathione, 7 parts of compound vitamin, 3 parts of carotene, 40 parts of compound staple food powder, 4 parts of compound mineral substance and 2 parts of green tea polyphenol.
3. The composition according to claim 1, wherein the nutritional requirements of a diabetic patient are as follows: the compound vitamin is prepared by compounding vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K and folic acid according to the mass ratio of 1:1.5:1:0.5:3:2:3:0.5:0.5:0.8: 1.
4. The composition according to claim 1, wherein the nutritional requirements of a diabetic patient are as follows: the composite staple food powder is prepared by compounding fine grinding powder of oat, oatmeal, corn flour, brown rice and wheat bran according to the mass ratio of 1:1:0.5:0.5: 0.5.
5. The composition according to claim 1, wherein the nutritional requirements of a diabetic patient are as follows: the compound mineral is formed by compounding calcium, magnesium, potassium, sodium, phosphorus, chlorine, selenium, iron, zinc and iodine according to the mass ratio of 1:1:1:1:1:1:0.2:0.1: 0.05.
6. A method of preparing a composition for satisfying the nutritional needs of a diabetic patient, comprising: the method comprises the following steps:
the method comprises the following steps: mixing and stirring low-ester pectin, chitin, soybean polysaccharide, fructo-oligosaccharide, agaric polysaccharide, porphyra polysaccharide, algal polysaccharide, glutathione, compound vitamin, carotene and compound mineral substances, and then uniformly mixing for 6-8 minutes by a mixer to prepare a mixture A;
step two: mixing the mixture A with rhizoma Amorphophalli powder, rapidly parching at 100 deg.C for 5-7 min, naturally cooling, and mixing with green tea polyphenols to obtain composition;
step three: sterilizing the composition, packaging, inspecting quality, and packaging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910969761.0A CN110623269A (en) | 2019-10-12 | 2019-10-12 | Composition for meeting nutritional requirements of diabetic patients and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910969761.0A CN110623269A (en) | 2019-10-12 | 2019-10-12 | Composition for meeting nutritional requirements of diabetic patients and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110623269A true CN110623269A (en) | 2019-12-31 |
Family
ID=68974803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910969761.0A Pending CN110623269A (en) | 2019-10-12 | 2019-10-12 | Composition for meeting nutritional requirements of diabetic patients and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110623269A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143010A (en) * | 2006-09-15 | 2008-03-19 | 上海瑞品实业有限公司 | Special-purpose nutritive food for diabetes patient and its preparation method |
CN101507494A (en) * | 2009-02-12 | 2009-08-19 | 刘志伟 | Special diet food for patient with hyperlipidemia and hypertension |
CN101829160A (en) * | 2010-05-06 | 2010-09-15 | 广东省食品工业研究所 | Functional composition with functions of controlling blood sugar and enhancing nutrition |
CN103238897A (en) * | 2013-05-02 | 2013-08-14 | 广州施健生物科技有限公司 | Composite plant solid drink suitable for diabetic patients |
CN106072533A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas of diabetes patients |
CN106135797A (en) * | 2015-04-27 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to regulation blood glucose and preparation method thereof |
CN106174474A (en) * | 2016-07-05 | 2016-12-07 | 郑州和正生物科技有限公司 | A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible |
-
2019
- 2019-10-12 CN CN201910969761.0A patent/CN110623269A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143010A (en) * | 2006-09-15 | 2008-03-19 | 上海瑞品实业有限公司 | Special-purpose nutritive food for diabetes patient and its preparation method |
CN101507494A (en) * | 2009-02-12 | 2009-08-19 | 刘志伟 | Special diet food for patient with hyperlipidemia and hypertension |
CN101829160A (en) * | 2010-05-06 | 2010-09-15 | 广东省食品工业研究所 | Functional composition with functions of controlling blood sugar and enhancing nutrition |
CN103238897A (en) * | 2013-05-02 | 2013-08-14 | 广州施健生物科技有限公司 | Composite plant solid drink suitable for diabetic patients |
CN106135797A (en) * | 2015-04-27 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to regulation blood glucose and preparation method thereof |
CN106072533A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas of diabetes patients |
CN106174474A (en) * | 2016-07-05 | 2016-12-07 | 郑州和正生物科技有限公司 | A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102771635B (en) | Mixed feed for early weaned piglets | |
CN104286849A (en) | Diabetes-specific enteral nutrition multi-polymerization agent | |
CN102711513A (en) | Compositions including pyruvate for companion animals and methods of use thereof | |
US20190015470A1 (en) | Garlic compositions | |
CN107647156A (en) | It is a kind of to reduce horizontal pig starter feed of serum lipopolysaccharides and its preparation method and application | |
CN107712874A (en) | Depth hydrolysis' protein prescription powder and technique manufacturing method | |
CN103919076A (en) | Carrot bean vermicelli | |
CN111642641A (en) | Pig feed and preparation method thereof | |
CN103734527A (en) | Concentrated feed applicable to lactating sows at lactation period | |
CN103385375A (en) | Antibiotic-free compound feed for fryers | |
CN107890117A (en) | A kind of compound oligomeric peptide nutrient powder of WPC | |
CN103750102A (en) | Composition with sugar-reducing effect and containing blackberries and preparation method for composition | |
CN110623269A (en) | Composition for meeting nutritional requirements of diabetic patients and preparation method thereof | |
CN108378296A (en) | Peri-operation period nutraceutical | |
CN107183696A (en) | A kind of health food and preparation method thereof | |
EP4331601A1 (en) | Food composition and pharmaceutical composition for preventing or alleviating sarcopenia, containing low-molecular-weight collagen as active ingredient | |
CN104509730A (en) | Mixed feed containing probiotics for black fry eel and preparation method thereof | |
KR20170053723A (en) | Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor | |
CN101524153A (en) | Health-care wheat flour beneficial for diabetes patients | |
CN114601172A (en) | Formula food of glutamine composition with special medical application and preparation method thereof | |
CN101366452A (en) | Cysteamine hydrochlorate composite premixed material for meat-poultry dynamiting and preparation method | |
CN114451560A (en) | Dietary composition for diabetic patients and application thereof | |
NL2030665A (en) | Antibiotic - free feed for improving production performance of weaned piglets and preparation method thereof | |
CN105248998A (en) | Fodder for eels | |
KR101252249B1 (en) | Fermented composition using effective micro-organisms and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191231 |
|
WD01 | Invention patent application deemed withdrawn after publication |